Quest Diagnostics

Infobox Company
name = Quest Diagnostics

type = Public (nyse|DGX)
genre =
foundation = New York, U.S. (1969)
founder =
location_city = Madison, New Jersey
location_country = U.S.
location =
locations =
area_served =
key_people = Surya Mohapatra (CEO)
industry =
products =
services = Clinical laboratory
revenue =
operating_income =
net_income =
assets =
equity =
owner =
num_employees =
parent =
divisions =
subsid =
homepage = [http://questdiagnostics.com/ QuestDiagnostics.com]
footnotes =
intl =

Quest Diagnostics Incorporated (NYSE|DGX) is a United States corporation which provides clinical laboratory services. The company has operations in the United States, United Kingdom, Mexico and through its wholly-owned subsidiary Quest Diagnostics India Pvt. Ltd, a laboratory in India [2/20/2008 News Release: Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India. http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=1110178&highlight=India] in addition to service locations located in Brazil. Quest Diagnostics also has collaborative agreements internationally with various hospitals and clinics. [Quest Diagnostics: Our Growing International Presence http://www.questdiagnostics.com/brand/business/b_bus_lab_presence.html] Quest Diagnostics also has operations in the US Territory of Puerto Rico. [ Quest Diagnostics: International Facilities & Operations http://www.questdiagnostics.com/brand/company/b_comp_intl_facilities.html]

Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company's corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Madison, New Jersey [10/24/2007 News Release: Quest Diagnostics Reports Third Quarter Results. Note new location of press release http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=1066622&highlight=] having moved there in October 2007 from Lyndhurst, New Jersey.

History

* 1969: Founded by Paul A. Brown, MD as MetPath, Inc., in New York.
* 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
* 1997: Quest Diagnostics becomes an independent company as a spin-off from Corning.
* 1997: Acquires clinical laboratory division of Branford, CT-based Diagnostic Medical Laboratory, Inc. (DML) [Quest Diagnostics Acquires Assets Of Diagnostics Medical Laboratory Inc. http://phx.corporate-ir.net/phoenix.zhtml?c=82068&p=irol-newsArticle&ID=199488&highlight=] .
* 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock.
* 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
* 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
* 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
* 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for approximately $934 million.
* 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
* 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
* 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.
* 2007: Acquires AmeriPath, becoming the leading provider of cancer diagnostic testing services.

Key Facts

* The nation's leading provider of diagnostic testing, information and services.
* Processed more than 151 million test requisitions in 2006.
* Approximately 43,500 full time employees.
* More than 33 regional laboratories in key U.S. markets, plus the UK and Mexico.
* Approximately 2,000 patient service centers.
* Revenues of approximately $6.7 billion in 2007.
* Leadership in gene-based and esoteric testing.
* Leadership in workplace drug testing.
* Leadership in risk assessment services for life insurers.

ee also

*Medical technologist

External links

* [http://www.questdiagnostics.com/ Corporate web site]
* [http://www.medplus.com/ MedPlus web site]

References